Uganda: Drug Giants Move in to Block Generics

Just months after the Indian Supreme Court blocked the evergreening of Novartis’ Gleevec, Ugandan health experts argue against stringent intellectual property protections in the Trade Related Aspects of Intellectual Property Rights.
allAfrica